Total Payments
$7,152
2024 Payments
$1,569
Companies
30
Transactions
355
Medicare Patients
21,352
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$6,872 (96.1%)
Education$279.97 (3.9%)
Other$0.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,872 | 351 | 96.1% |
| Education | $279.97 | 3 | 3.9% |
| Grant | $0.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,458 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $1,161 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $611.12 | 46 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $591.34 | 27 | $0 (2024) |
| PFIZER INC. | $482.51 | 31 | $0 (2024) |
| GENZYME CORPORATION | $451.55 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $374.65 | 13 | $0 (2024) |
| Lilly USA, LLC | $287.18 | 13 | $0 (2023) |
| LEO Pharma Inc. | $208.06 | 9 | $0 (2019) |
| UCB, Inc. | $196.86 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,569 | 78 | ABBVIE INC. ($399.02) |
| 2023 | $1,719 | 82 | AbbVie Inc. ($401.62) |
| 2022 | $1,058 | 45 | Janssen Biotech, Inc. ($272.11) |
| 2021 | $291.20 | 14 | Janssen Biotech, Inc. ($87.57) |
| 2020 | $160.24 | 8 | AbbVie Inc. ($45.84) |
| 2019 | $1,080 | 59 | AbbVie, Inc. ($155.20) |
| 2018 | $626.51 | 36 | Janssen Biotech, Inc. ($127.87) |
| 2017 | $648.36 | 33 | GENZYME CORPORATION ($114.95) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.06 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.56 | General |
| Category: Immunology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.28 | General |
| 10/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.31 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Immunology | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: Immunology | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.53 | General |
| Category: Immunology | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 5,901 | 12,355 | $2.8M | $512,836 |
| 2022 | 30 | 5,545 | 11,669 | $2.7M | $501,650 |
| 2021 | 31 | 5,226 | 10,684 | $2.1M | $485,703 |
| 2020 | 28 | 4,680 | 8,601 | $1.5M | $395,853 |
Total Patients
21,352
Total Services
43,309
Medicare Billing
$1.9M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,728 | 2,498 | $756,894 | $154,935 | 20.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 698 | 894 | $350,448 | $66,565 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 961 | 1,295 | $349,650 | $50,911 | 14.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 166 | 210 | $249,480 | $48,927 | 19.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 793 | 5,352 | $191,520 | $28,060 | 14.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 248 | 282 | $125,772 | $23,712 | 18.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 118 | 147 | $87,318 | $18,832 | 21.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 245 | 453 | $97,848 | $18,460 | 18.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 139 | 176 | $171,072 | $18,062 | 10.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 126 | 153 | $86,751 | $13,905 | 16.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 57 | 85 | $59,670 | $9,473 | 15.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 25 | 27 | $18,225 | $8,224 | 45.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $48,604 | $8,079 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 88 | $38,016 | $7,670 | 20.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 25 | 26 | $30,186 | $6,287 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 127 | $24,003 | $5,125 | 21.3% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 25 | 27 | $13,500 | $3,202 | 23.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $15,603 | $3,051 | 19.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 22 | 22 | $15,444 | $2,685 | 17.4% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 21 | 21 | $23,247 | $2,423 | 10.4% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 15 | 137 | $13,015 | $2,379 | 18.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $22,286 | $2,304 | 10.3% |
| 69100 | Biopsy of ear | Office | 2023 | 32 | 36 | $14,112 | $2,112 | 15.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 22 | $10,406 | $1,951 | 18.8% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $10,368 | $1,866 | 18.0% |
About Dr. Caitlin Carney, MD
Dr. Caitlin Carney, MD is a Dermatology healthcare provider based in Newburyport, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821251836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caitlin Carney, MD has received a total of $7,152 in payments from pharmaceutical and medical device companies, with $1,569 received in 2024. These payments were reported across 355 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,872).
As a Medicare-enrolled provider, Carney has provided services to 21,352 Medicare beneficiaries, totaling 43,309 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Newburyport, MA
- Active Since 07/09/2008
- Last Updated 10/18/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821251836
Products in Payments
- SKYRIZI (Biological) $988.15
- Sotyktu (Drug) $641.71
- REMICADE (Biological) $635.39
- TREMFYA (Drug) $588.97
- EUCRISA (Drug) $482.51
- ILUMYA (Biological) $392.73
- DUPIXENT (Biological) $349.00
- Humira (Biological) $295.78
- TALTZ (Drug) $287.18
- DUPIXENT (Drug) $243.93
- ENSTILAR (Drug) $208.06
- Cimzia (Drug) $196.86
- Otezla (Drug) $179.62
- VTAMA (Drug) $163.76
- LIBTAYO (Biological) $150.72
- XTRAC (Device) $123.87
- XEOMIN (Biological) $106.33
- Zoryve (Drug) $94.17
- DUPIXENT DUPILUMAB INJECTION (Biological) $82.55
- SOOLANTRA (Drug) $77.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.